In a recent survey, researchers identified rising costs, socioeconomic inequity, and drug trends as major concerns for large employers.
More employers report cancer as the top driver of health care costs in large companies, according to the 2023 Large Employers’ Health Care Strategy and Plan Design Survey, administered by the Business Group on Health.
Cancer, cardiovascular disease, and musculoskeletal conditions have peaked as the top 3 conditions driving health care costs for 2 years in a row in the survey. However, employers reported a 13% increase in late-stage cancers and approximately 44% predict a similar increase in the future because of delayed screenings caused by the COVID-19 pandemic.
“Survey findings function as a ‘collective snapshot’ that can guide employers as they determine how to maximize employee benefits,” said Ellen Kelsay, president, and CEO of Business Group on Health, in a press release.
Employers are concerned beyond their own costs, according to the survey, including concerns about health equity and affordable health care. Employers claim that they will invest in health and well-being offerings for employees.
Between May 31, 2022, and July 13, 2022, the researchers administered the survey to 135 large companies, who share a total of more than 18 million employees. The survey aggregated employer-sponsored health care data, including costs and health care plan design, for 2023.
Employers’ major areas of concern included:
Kelsay and team found that employers could create “a more positive and sustainable health care experience, among other issues,” because of these findings.
Business Group on Health. Cancer Now Top Driver of Employer Health Care Costs, Says Business Group’s 2023 Health Care Strategy and Plan Design Survey. News Release. August 23, 2022. Accessed on August 23, 2022.